~/blog/hemp-delay-signed-what-section-2019-actually-moves
The Hemp Delay Is Signed. It Only Delays Part of the Rule.
The White House says H.R. 6500 was signed on 2 September. Its section 2019 is written as a scope limit, not a new date — so a narrow slice still leaves the hemp definition on 12 November, and the 0.4 mg per-container ceiling waits until 11 December.
The delay is law. It is also not the delay the headlines describe.
What was signed
The White House published a notice dated Wednesday, 2 September 2026 saying the President signed H.R. 6500 into law — the “Continuing Appropriations and Extensions Act, 2027.” The notice describes a stopgap funding federal agencies through 11 December 2026. It does not mention hemp.
The hemp material is section 2019, one paragraph in division B, headed “Section 781 Extension.”
What it actually says
Verbatim, from the enrolled text: “Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781).”
A scope limit, not a date change — and the difference is the story. The 12 November effective date was never repealed; for 29 days the redefinition simply narrows to two paragraphs.
Two dates now, not one
Those two paragraphs are one test at two stages — (ii)(I) for intermediate hemp-derived cannabinoid products, (iv)(I) for final ones — both describing cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” That slice leaves the hemp definition on 12 November.
The rest of the redefinition waits for 11 December: the exclusion for cannabinoids the plant can make but which were “synthesized or manufactured outside the plant”; the 0.3 percent combined-total test on intermediates; the rewritten headline definition trading the delta-9 percentage for total tetrahydrocannabinols, THCa included; and the ceiling of 0.4 milligrams combined total per container on final products.
That last one reprices a shelf. A single 5 mg gummy is twelve and a half times the ceiling — arithmetic on the statutory figure, not anything we weighed.
Two points of wording. The statute excludes these products from the definition of “hemp”; what follows is a controlled-substance question this text does not settle. And the sorting key for November — which cannabinoids the plant can make on its own — is what the FDA lists were meant to specify; searching again on 3 September, we found no sign those lists have been published.
Reading the map
The two countdown clocks we read on 29 August were both ticking to 12 November. That date still stands, as we argued then, but only for the slice section 2019 leaves in place. A banner that reflips wholesale to 11 December is wrong the other way.
And a federal calendar moving does not move anybody else’s. State cut-offs sit in state statutes and shift when legislatures shift them — so, the reflex: check your state, and read effective dates rather than headlines. Nothing in this act authorises or approves any product or brand — it redraws a definition, nothing more. Nothing here is health guidance, and none of it is for anyone under 21.